Cheers. I hope they are conservative as well !
Forecast is actually 40,000 units "placed", as 12,500 leased and in field.
First production run is 10k units, they arrive in October.
I reckon next production run can't be planned until the IPO is done & $'s in bank.
Let's up it to 15,000 Pulse units for the 2nd run, delivery March. cost of production for 15,000 units is around $1M ( 15,000 x $65 ( estimate ) ).
So if these are pre-sold, 25,000 units sold/leased by end March across both production runs..
That leaves another production run of 15k delivered and sold/leased in April - June.
Sounds about right.
Upside is of course if they land a big order from someone like Walgreens Clinical Trial business, and virtually make to order.
If it was me though, I would want at least two "smaller" production runs delivered & QA approved before supplying to someone like Walgreens.
FY 24/25 however, all guns blazing !
Add to My Watchlist
What is My Watchlist?
